2026 10 15 Opioid Stewardship in Palliative Care
Keywords
Summary
164 words
Critical Evaluation
Value of the Information & Strength of the Argument
The lecture provides practical, actionable advice for clinicians. Rauch argues that opioid stewardship extends beyond safe prescribing to include deprescribing and monitoring. He supports his claims with statistics on diversion and substance use disorder prevalence. The argumentation is coherent, emphasizing harm reduction over abstinence. He addresses common clinical dilemmas such as early refills and unexpected urine drug screen results, offering a stepwise approach that prioritizes patient safety and engagement. The use of personal experience and team-based philosophy strengthens the practical value.
Scientific Rigor, Source Quality, Title Accuracy
The lecture is based on expert opinion and clinical experience, but specific citations are not provided. Rauch references CDC, FDA, and the Journal of Pain and Symptom Management without detailing specific studies. While the content aligns with current medical guidelines, the lack of explicit references limits verifiability. The title accurately reflects the content, though the date prefix in the title is unusual and not descriptive. Overall, the lecture is scientifically sound and consistent with best practices, but it would benefit from citing specific evidence.
180 words
Title / Content Match
The title accurately describes the topic, but the date prefix appears transient and does not affect content.
Quality & Reliability
7/10
The lecture provides reliable, evidence-aligned information from a board-certified expert, though it lacks explicit citations and direct references in the description.
Key Moments
Markers derived by PSI from the transcript: the creator did not define chapters.
- Definition of opioid stewardship and its importance.
- Statistics on substance use disorder in cancer patients and diversion.
- Risks of abrupt opioid discontinuation and overdose risks.
- Introduction of harm reduction strategies and example of naloxone.
- Prognosis-guided prescribing and setting patient expectations.
- Management of early refill requests and educational interventions.
- Consideration for buprenorphine and gentle weaning.
Contribution & Novelties
Original contribution: This lecture offers a practical, team-based approach to opioid stewardship in palliative care, bridging the gap between addiction medicine and palliative care. It provides actionable strategies for handling common clinical challenges such as early refill requests and unexpected urine drug screens, emphasizing education and support over punitive actions. The novel concept of ‘prognosis-guided prescribing’ and the use of harm reduction principles tailored to oncology patients are highlighted.
Pour aller plus loin :
- Harm reduction — Overview of harm reduction principles and applications.
- Buprenorphine — Information on buprenorphine, an effective medication for opioid use disorder and pain.
- Harrison Narcotics Tax Act — Historical law affecting opioid prescribing for addiction.
110 words
Radar Profile
The radar indicates high scores in quality and quantity, with moderate technical depth and reliability. This suggests a comprehensive and trustworthy educational lecture suitable for medical professionals.